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The application of next generation sequencing techniques has allowed the
characterization of the urinary tract microbiome and has led to the rejection of the pre-
established concept of sterility in the urinary bladder. Not only have microbial communities
in the urinary tract been implicated in the maintenance of health but alterations in their
composition have also been associated with different urinary pathologies, such as urinary
tract infections (UTI). Therefore, the study of the urinary microbiome in healthy individuals,
as well as its involvement in disease through the proliferation of opportunistic pathogens,
could open a potential field of study, leading to new insights into prevention, diagnosis and
treatment strategies for urinary pathologies. In this review we present an overview of the
current state of knowledge about the urinary microbiome in health and disease, as well as
its involvement in the development of new therapeutic strategies.
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The human body is colonized by at least the same number of microorganisms than somatic cells. In
fact, the estimated ratio of bacteria to human cells is 1.3:1, considering nucleated and enucleated
cells (Sender et al., 2016).
The term ‘microbiota’ is used to refer to the group of microorganisms associated to a specific
biologic niche (Banerjee and Robertson, 2019). The human microbiota is composed of 500-1000
bacterial species, with genomes containing thousands of genes, which offers a much greater diversity
and genetic versatility than the human genome (Locey and Lennon, 2016). Moreover, many other
microorganisms in the human body, such as protozoa, fungus, archaea and virus, are also part of the
human microbiota.
There is a consensus regarding the beneficial role of these microorganisms in maintaining the
homeostasis in the human body. The microbiota carries out important protective functions against
pathogens through the formation of a physical barrier and contributes to the development of the
immune system (Wang B. et al., 2017).
Alteration in the microbiota has been associated with the development of several pathologies,
such as obesity (Riva et al., 2017), inflammatory bowel disease (Walters et al., 2014), ulcerative
colitis (James et al., 2015), Crohn disease (Gutin et al., 2019), non-alcoholic fatty liver diseasegy | www.frontiersin.org May 2021 | Volume 11 | Article 6170021
Pérez-Carrasco et al. Urinary Microbiome(Ma et al., 2017), insulin resistance syndrome (Saad et al., 2016),
type II diabetes mellitus (Sikalidis and Maykish, 2020),
Alzheimer’s disease (Jiang et al., 2017), atopic eczema
(Abrahamsson et al., 2012), allergies (Tanaka et al., 2017)
or asthma (Wu et al., 2016), among others. Therefore,
gaining insight into the microbial composition of the human
body and its alteration in pathological conditions might
favor the development of new prophylactic, diagnostic and
therapeutic strategies.
Similarly, the term ‘microbiome’ refers to the group of
microbial genomes in a specific environment (Cimadamore
et al., 2019). The great importance of microbial communities
in the human body promoted the study and characterization of
the microbiome in different human healthy body environments.
The Human Microbiome Project has analyzed the composition
of bacterial communities in several human body niches such as
the oral cavity, skin, gastrointestinal tract or vagina, and its role
in health and disease (Huttenhower et al., 2012). Initially, the
urinary bladder was not included in the study because urine was
traditionally considered sterile due to the assumption of
pathogenicity for all bacteria (Zasloff, 2007). However, the
development of high-throughput DNA sequencing techniques
has led to the identification of the commensal microbial
community in the urinary tract (Wolfe and Brubaker, 2015).
In this review, the current state of knowledge in relation to the
urinary microbiome, or urobiome, is presented, with a focus onFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 2its importance for health maintenance and its role in the
development of disease.THE EVOLUTION OF URINARY
MICROBIOME ANALYSIS:
METHODOLOGY AND LIMITATIONS
Traditionally, the detection of microorganisms in the urinary
tract was based on standard urine cultures (Figure 1),
implemented in clinical microbiology laboratories. These
methods only allow the detection of a limited number of
microorganisms, mainly aerobic and fast-growing bacteria,
such as Escherichia coli (Garcıá and Isenberg, 2010; Wolfe and
Brubaker, 2015). Anaerobic microorganisms characterized by
slow growth or bacteria with complex nutrient needs are,
however, not detected using this approach.
The metagenomic analysis using Next Generation Sequencing
(NGS) has facilitated the quantitative characterization of
microbiomes, providing information on microbial populations
and helping to discover uncultured microbes (Wolfe and
Brubaker, 2015; Ishihara et al., 2020). Two approaches could
be taken as far as NGS techniques are concerned: amplicon
sequencing and shotgun sequencing (Figure 1). The first one
consists of PCR-based analysis focused on marker genes, such as
16S rRNA subunit, with nine hypervariable regions (V1-V9)FIGURE 1 | Microbial identification methods for urine samples. Bacteria in urine samples can be identified by different methods: culture-based methods (standard
urine culture or enhanced quantitative urine culture (EQUC)) or sequencing-based methods (amplicon sequencing or shotgun sequencing).May 2021 | Volume 11 | Article 617002
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species and highly conserved interregional sequences for primer
design (Wolfe and Brubaker, 2015; Aguilera-Arreola et al., 2016).
The second one allows to sequence whole microbiome in a wide
variety of samples (Jovel et al., 2016) including non-bacterial
components such as viruses or fungi (Moustafa et al., 2018). NGS
has enabled the identification of commensal and pathogenic
species as well as identify new emerging uropathogens (Fouts
et al., 2012; Lewis et al., 2013; Nienhouse et al., 2014).
However, one limitation of DNA sequencing-based methods
is its inability to show the viability of the identified bacteria. For
this reason, urine culture protocols have been improved aiming
for broadening the range of potentially detectable bacteria. The
use of the enhanced quantitative urine culture (EQUC) protocol
is recommended to study the viability of bacteria in urine
(Figure 1) (Price et al., 2016). This protocol consists of plating
a urine sample in a set of media including blood agar plate,
chocolate and colistin-nalidixic acid agars and incubating them
under aerobic or anaerobic conditions at 35°C for 48 hours (Price
et al., 2020). A greater diversity of bacteria can be cultured
following this procedure, but if used as diagnostic tools, their
results must be correctly interpreted since the identified
microorganisms may appear in both patients and healthy
individuals (Coorevits et al., 2017). Therefore, a combination
of 16S rRNA gene sequencing along with EQUC would provide a
reliable characterization of microbial communities in the urinary
tract, since culture-based approaches would allow an
approximate bacterial quantification and would therefore be
useful as clinically relevant indicators.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3Another relevant problem in urobiome studies is the choice of
specific methods for sample collection, since those may affect the
obtained results. The main current methods for urine sample
collection are shown in Figure 2.
Many studies use midstream urine samples or spontaneously
voided urine, being the its first milliliters discarded as they may
be contaminated with bacteria from the skin (Lewis et al., 2013;
Gottschick et al., 2017). Not being a sterile collection method,
midstream urine samples may contain microbial contamination
with bacteria from the uroepithelium, periurethra or the genital
tract, thus misleading the proper characterization of the urinary
bladder microbiome in favor of the urogenital microbiota (Fouts
et al., 2012; Modena et al., 2017). Not even the joint use of funnels
for urine collection and silver antimicrobial wipes have
prevented sample contamination (Lough et al., 2019). This
sample collection method presents issues related to the
different sources of contamination in men and women, due to
obvious anatomic differences. In women, the main source of
contamination during midstream urine sample collection is the
vulvovaginal tissue and it is not easily avoidable (Wolfe et al.,
2012). The risk of contamination in midstream urine samples in
men is lower, but there is also a chance of introducing microbial
load from nearby tissues, such as urethra, is present (Kartens
et al., 2018).
Another widely used method to collect urine samples consists
of using transurethral catheters. Both straight intermittent and
permanent transurethral catheters reduce the contamination
compared to midstream urine sample. However, this is a more
invasive technique and urethral bacteria might still contaminateFIGURE 2 | Collection methods for urine samples. Urine samples can be collected by different methods: collection of spontaneous midstream urine, catheterization
with an intermittent or permanent catheter or suprapubic aspiration from the bladder. Differences between these methods lie in the grade of possible bacterial
contamination from other areas such as the urethra, the skin or the genital apparatus, and the grade of invasion in each technique. The number of arrows indicates
the grade of contamination depending on the collection method used.May 2021 | Volume 11 | Article 617002
Pérez-Carrasco et al. Urinary Microbiomesamples during catheter insertion (Akmal-Hasan et al., 2014),
especially in the case of permanent catheters. Hence, the best
option for the collection of urine samples in studies regarding the
urinary microbiome is suprapubic aspiration, since it is
performed directly from the bladder avoiding the contact with
other areas. Thus, data regarding the composition of the urinary
bladder microbiome using this method are more accurate than
those obtained through other routines (Eliacik et al., 2016).
However, this is the most invasive, painful and complicated
collection method (Badiee et al., 2014); a comparative study of
microbial communities in urine obtained either with suprapubic
aspiration or transurethral catheter has shown that the outcome
is very similar regardless of the collection method, which makes
transurethral catheterized samples widely accepted for the study
of the urinary bladder microbiome (Wolfe et al., 2012).
A recent study has set the benchmark for the storage and
collection conditions of urine when assessing the female urinary
microbiome. The authors conclude that shorter storage times
(periods not exceeding four days) and colder temperatures
(below 4°C) are the most favorable conditions before long-
term storage at -80°C; the reproducibility significantly
improved when DNA preservatives (such as Assay Assure ®)
were added to the sample (Jung et al., 2019).
The low biomass of the urinary microbiota (<105 colony-
forming units per milliliter, approximately) (Pearce et al., 2014)
and its proximity to other bacterial niches with higher microbial
biomass, such as the vagina or the gut, makes it necessary to take
extreme precautions to avoid the introduction of contamination
during sample collection, processing and data analysis (Kartens
et al., 2018). Contaminant DNA is an important issue in
microbiome studies, especially in low biomass communities
where they might become more evident and contaminant taxa
might be overrepresented. These contaminations can derive from
laboratory environments, manipulation, reagents and amplicons
or DNA from other samples (cross-contamination). For this
reason, adding DNA extraction blanks and no-template controls
is essential in microbiome studies (Eisenhofer et al., 2019).URINARY MICROBIOME OR UROBIOME
It is worth bearing in mind that the term “urinary microbiota”,
refers to the microbial community in bladder-obtained urine,
and its full characterization is still under development (Wolfe
and Brubaker, 2015; Pohl et al., 2020). The number of reports on
the human urobiome is very limited and most of these studies are
focused on characterizing microbial communities in either
women or men. In addition, due to the low number of cases
included in these studies, and other variables such as gender, race
or geographical distribution, it is still early to accurately define
the composition of the urinary microbiome in the whole
population and in specific subgroups, such as individuals
suffering systemic diseases.
In general, the microbiota in urine is less abundant and less
diverse than the microbiota in other sites of the body, such as the
gut. For instance, the female urinary microbiota is estimated toFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4contain 104 – 105 colony-forming unit (CFU)/ml in comparison
with 1012 CFU/g in feces (Pearce et al., 2014).
Catheterized-urine used in most urinary microbiome studies
provides us with an overview of the microbial community
present in the urinary bladder. However, it is possible that
some bladder mucosa-associated bacteria are not detected in
these type of urine samples. For its detection it would be
necessary to take biopsies or tissue samples. In fact, a recent
study compared the urinary microbiota from catheterized-urine
samples with the bladder mucosa-associated microbiota using
tissue samples in patients suffering bladder cancer. Important
differences in some taxa were found in this study, which suggest
that the bladder tissue microbiota and the urinary microbiota
might differ to some extent (Mansour et al., 2020).
The 16S rRNA sequencing-based characterization of the
urinary microbiome, or urobiome, is similar for men and
women at the phylum level. In both genders, the majority of
bacteria belong to the Firmicutes phylum (65% in males vs 73%
in females). The remainder phyla, accounting for up to 97%
considering Firmicutes, are Actinobacteria (15% males vs 19%
females), Bacteroidetes (10% males vs 3% females) and
Proteobacteria (8% males vs 3% females) (Modena et al., 2017)
(Figure 3A).
Most genera are shared in the urinary microbiome of healthy
men and women. Common genera are Prevotella, Escherichia,
Enterococcus, Streptococcus or Citrobacter among others, while
genus Pseudomonas has only been described in men (Modena
et al., 2017). Overall, the main difference in the composition of
the urobiome between genders is found in the abundance of
some genera such as Corynebacterium and Streptococcus, more
abundant in men, or Lactobacillus, more abundant in women
(Fouts et al., 2012; Modena et al., 2017). A general description of
the main bacterial genera identified in the healthy female and
male urinary microbiota is included in Table 1.
Some specific adaptations of the urinary microbiota to
colonize the urinary tract have been described. Similar to the
uropathogenic Escherichia coli (Sokurenko et al., 1998), some
members of the urinary microbial community could use type 1
fimbriae to bind to specific urothelial proteins, uroplakins, using
them as binding sites. Other factors such as pH, oxygen tension
or nutrient availability have been described as key determinants;
changes in oxygen tension have been associated with alterations
in the urinary microbiota (Shannon et al., 2019). In addition,
some members of the urinary microbial community, such as
Lactobacillus or Streptococcus, have glycosaminoglycan-
degrading enzymes, being able to metabolize the urothelium
layer and favoring the availability of sugars (Kawai et al., 2018).
Most of the urobiome studies have been focused on bacteria
although the presence of fungi, viruses and archaea in urobiome
has also been described. The urinary fungal community has not
been well characterized, especially in healthy individuals. The
presence of Candida spp. has been reported in catheterized urine
samples from healthy individuals (Pearce et al., 2014). Some
preliminary data from a more recent study show the presence of
a urinary fungal community formed mainly by individuals of
Dothiodeomycetes, Saccharomycetes (where Candida belongs),May 2021 | Volume 11 | Article 617002
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classes (Ackerman and Underhill, 2017). However, the use of
midstream urine samples in this analysis may have skewed the
data due to possible contaminations from nearby tissues, such as
vagina, where the presence of Candida has been widely
documented (Drell et al., 2013). To date, only one species of
archaea has been reported to be associated with disease in the
urinary microbiome (Grine et al., 2019). On the other hand, the
viral community in the urinary tract is mainly composed of
bacteriophages, although some eukaryotic viruses have also been
described. The urinary virome will be described in detail in
section 5 of this review.
There are few studies on the specific role of the urinary
microbiota in the maintenance of homeostasis and its underlying
mechanisms. Similar to other human microbial communities,
the urinary microbiota could play a role in modulating the
immune response (Jones-Freeman et al., 2021). In fact, it has
been shown that some microbial metabolites may be involved in
the regulation of the immune response and inflammation during
urinary diseases (El-Deeb et al., 2019).
Healthy Female Urinary Microbiome
The most abundant genus found in the urinary microbiome in
healthy women is Lactobacillus (Fouts et al., 2012; Pearce et al.,
2014; Modena et al., 2017; Price et al., 2020). However, not allFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5Lactobacillus species are associated with a healthy microbiota. In
fact, L. crispatus has been associated with a state of health, while
other species such as L. gasseri, have been associated with
pathologies, such as urgency urinary incontinence (UUI)
(Pearce et al., 2014). In addition, a decrease in the abundance
of Lactobacillus has been related to pathological states, since its
detriment favors the colonization of disease-causing
uropathogens (Fouts et al., 2012). Gardnerella comes a close
second in terms of abundance, with Gardnerella vaginalis being
the most abundant species harboring some pathogenic strains;
some of them might cause urinary tract infections mostly in
women, and less frequently in men (Pearce et al., 2014; Ruiz-
Gómez et al., 2019).
Urinary bacterial communities are grouped into urotypes in
which a particular bacterial genus predominates (Mueller et al.,
2017). Various urotypes, named after its respective dominant
genus, have been identified, such as Prevotella, Sneathia,
Gardnerella, Atopobium, Lactobacillus, Shigella, Escherichia,
Enterococcus, Streptococcusor and Citrobacter (Gottschick et al.,
2017). Some of them, such as urotypes dominated by
Lactobacillus crispatus, Gardnerella vaginalis and Atopobieum
vaginae, are exclusive for healthy women, while others appear
frequently associated with some disease.
The origin of the urinary microbial community is not clear,
but different hypotheses are being under consideration in thisA
B
FIGURE 3 | Comparison between urinary, vaginal and gut bacterial communities. (A) Phyla relative abundance in urinary (Modena et al., 2017), vaginal (Diop et al.,
2019) and gut microbiota (Morand et al., 2019). (B) Venn diagram showing overlapping species between urinary (Morand et al., 2019), gut (Morand et al., 2019) and
vaginal (Diop et al., 2019) microbiota.May 2021 | Volume 11 | Article 617002




















70 genera identified: Actinobaculum, Actinomyces, Aerococcus,
Anaerococcus, Anaerosphaera, Anaerovorax, Arcanobacterium,
Arthrobacter, Atopobium, Azospira, Brevibacterium, Brooklawnia,
Butyricicoccus, Campylobacter, Catonella, Caulobacter,
Coriobacterium, Corynebacterium, Dialister, Enterobacter,
Enterocococcus, Facklamia, Fastidiosipila, Finegoldia,
Flavonifractor, Friedmanniella, Fusobacterium, Gallicola,
Gardnerella, Gulosibacter, Helcococcus, Howardella,
incertae_sedis, Jonquetella, Lachnospiracea_, Lactobacillus,
Methylovirgula, Microvirgula, Mobiluncus, Modestobacter,
Murdochiella, Negativicoccus, Neisseria, Oligella, Paraprevotella,
Parvimonas, Pelomonas, Peptococcus, Peptoniphilus,
Peptostreptococcus, Porphyromonas, Prevotella,
Propionimicrobium, Proteiniphilum, Rhodococcus, Rhodopila,
Saccharofermentans, Sneathia, Soehngenia, Sporanaerobacter,
Staphylococcus, Stenotrophomonas, Streptococcus,
Streptophyta, Sutterella, Tepidimonas, Tessaracoccus,
Thermoleophilum, TM7_genera_, Varibaculum






























Lactobacillus, Coagulase-negative Staphylococci, Peptococcus,
Corynebacterium, Propionibacterium, Eubacterium,
Peptostreptococcus, Candida, Bacteroides, Bacillus, Veillonella,
Enterobacteriaceae, Staphylococcus aureus, Enterococcus,



















5 most abundant genera: Lactobacillus, Corynebacterium,
Gardnerella, Prevotella, Bacillus













Predominant species in each urotype, respectively: Prevotella
amnii, Gardnerella vaginalis, Atopobium vaginae, Lactobacillus
iners, Shigella sonnei, Escherichia coli, Enterococcus faecalis,
Streptococcus agalacticie, Citrobacter murliniae, Lactobacillus
crispatus
6 urotypes identified.
Predominant species in each urotype,
respectively: Prevotella amnii, Sneathia















5 most abundant genera: Lactobacillus, Corynebacterium,
Staphylococcus, Streptococcus, Prevotella















Main genera identified: Lactobacillus, Staphylococcus,
Corynebacterium, Enterobacteriaceae, Finegoldia,
Streptococcus, Anaerococcus, Peptoniphilus, Varibaculum,


















Main species identified: Staphylococcus epidermidis,
Micrococcus luteus, Lactobacillus gasseri, Escherichia coli,
Streptococcus oralis, Neisseria perflava, Lactobacillus crispatus,
Lactobacillus jensenii, Gardnerella vaginalis, Rothia mucilaginosa,
Lactobacillus delbrueckii, Lactobacillus rhamnosus, Bacillus
infantis, Actinomyces odontolyticus, Bacillus idriensis,
Corynebacterium amycolatum, Streptococcus anginosus,
Streptococcus agalactiae, Gordonia terrae, Staphylococcus
warneri, Lactobacillus iners, Streptococcus mitis, Bifidobacterium
bifidum, Streptococcus gordonii, Aerococcus urinae,
Actinomyces neuii, Enterococcus faecalis, Streptococcus
(Continued)Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 May 2021 | Volume 11 | Article 617002
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urinary tract suggests that vagina might be the main source of the
urinary microbial community. Two recent reports have proposed
that the female urinary microbiota and the vaginal microbiota
are interconnected. In the first study (Thomas-White et al.,
2018a), the authors start analyzing cultured bacteria from the
female bladder and through a detailed comparison of the bladder
microbiome with the gastrointestinal and vaginal microbiomes,
they find a close similarity between the vaginal and bladder
microbiota, with distinctive functional abilities compared to
those observed in the gastrointestinal microbial communities.
A whole metagenome analysis of bacterial strains isolated from
vaginal and bladder samples from the same donor revealed a
great similarity between strains considering not only emerging
uropathogens, such as Escherichia coli and Streptococcus
anginosus, but also commensal members associated with health
such as Lactobacillus iners and L. crispatus. Based on this finding,
the author proposes the existence of a single urogenital
microbiota in both niches.
In the second study, Komesu et al. (2020) studied the
relationship between vaginal and urine microbiome by 16S
rRNA gene sequencing in samples from women suffering
mixed urinary incontinence and asymptomatic controls. They
observed a correlation at the operative taxonomic units (OTUS)
level between certain bacteria, such as Gardnerella, Prevotella,
Ureaplasma or Lactobacillus, in urine and vaginal samples,
suggesting the existence of a common urogenital microbiota.
Despite the common traits, the urinary and vaginal microbiome
show some differences, such as the absence of the urinary genera
Tepidomonas and Flavobacterium in the vaginal microbiota.
However, a recent study proposes that the origin of the
urinary microbiota is the gut. These authors show that 64% of
species identified in urine samples, using culture and 16S rRNA
gene sequencing-based methods, overlap with identified species
in the gut microbiota, while only 31% overlap with species
isolated from the vagina (Dubourg et al., 2020) (Figure 3B).
Additionally, the reduction of UTI incidence after fecal
microbiota transplantation seems to support this hypothesis
(Tariq et al., 2017).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7Healthy Male Urinary Microbiome
The number of reports on themale urinary microbiome is significantly
less than those on the female urobiome, especially in the case of healthy
subjects. The first studies on the male urobiome characterized the
microbial community inmidstreamurine and urethral swab samples in
patientswith andwithout sexual transmitted infections. 16S rRNAgene
amplification and sequencing made it possible to describe the presence
of a male urinary microbial community in healthy individuals, as well
as a dysbiosis associated with disease (Nelson et al., 2010; Dong
et al., 2011).
A recent study has analyzed the male urinary microbiome in
patients with and without urinary tract symptoms using EQUC
and 16S rRNA sequencing. This study has shown the importance
of using catheterized urine samples in male urobiome studies, as
well as in women. However, the small sample size in this study
has impaired the identification of significant differences in the
microbial communities of both populations (Bajic et al., 2020).
As mentioned previously, the differences found in the
composition of the healthy male and female urinary tract
microbiome are slight (Gottschick et al., 2017; Modena et al.,
2017). Urotypes such as those dominated by Prevotella, Shigella,
Enterococcus, Streptococcus and Citrobacter in the female urinary
microbiota have also been found in men (Gottschick et al., 2017).
Similar to Lactobacillus being the main genus in the female urinary
microbiota, the male microbiota is characterized by the
predominance of Corynebacterium (Fouts et al., 2012) and
Streptococcus (Modena et al., 2017). Lactobacillus and
Pseudomonas genera have also been described as members of the
male microbiota (Moustafa et al., 2018), although in the case of
Lactobacillus its proportion is lower compared to women (Modena
et al., 2017). Staphylococcus haemolyticus has been identified as an
abundant species in healthy men (Groah et al., 2016). Other shared
genera in the male and female urinary microbiota are coagulase-
negative staphylococci and Eubacterium (Kogan et al., 2015).
Changes in the Urinary Microbiome
Associated With Age
The effect of age on the microbial profiles in the urinary tract has









salivarius, Streptococcus sanguinis, Corynebacterium
aurimucosum, Actinomyces naeslundii, Streptococcus equinus,











Main genera identified: Lactobacillus, Streptococcus,
Tepidimonas, Prevotella, Flavobacterium, Escherichia,
Ureaplasma, Shuttleworthia, Aerococcus, Gardnerella, Veillonella,
Bacteroides, Enterobacter, Acidovorax, Sneathia, Clostridium,











4 predominant urotypes identified: Lactobacillus, Gardnerella,
Streptococcus and Escherichia urotypes.
Other genera also identified: Aerococcus, Alloscardovia,
Anaerococcus, Bifidobacterium, Corynebacterium,
Enterococcus, Finegoldia, Klebsiella, Prevotella, StaphylococcusMay 2021 | Volume 11 | Article 617002
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(Curtiss et al., 2018). A reduction in the relative abundance of
Lactobacillus (Liu et al., 2017; Curtiss et al., 2018; Komesu et al.,
2018), Bifidobacteria, Sneathia, Shuttlewothia or Bacillus (Liu
et al., 2017) has been observed in elderly women. Conversely,
genera such as Mobiluncus, Oligella or Porphyromonas, have a
higher prevalence in postmenopausal women (Curtiss et al.,
2018). Moreover, some urotypes are differently distributed
according to age, Escherichia urotype has been linked to
healthy older women, whereas Gardnerella urotype has been
associated with young women (Price et al., 2020).
In addition to changes in relative abundance, four genera
have been exclusively identified in men and women over 70
years: Jonquetel la, Parvimonas, Proteiniphilum and
Saccharofermentans (Lewis et al., 2013). The exclusive presence
of Parvimonas in postmenopausal women has been recently
confirmed (Curtiss et al., 2018). However, due to the low
number of participants in Lewis’ study (6 men and 10
women), the exclusive presence of the other three genera in
the elderly microbiota still needs to be confirmed.INFLUENCE OF THE URINARY
MICROBIOME ON DISEASE
The growing relevance of the study of the urinary microbiome
stems from the fact that alterations in its composition have been
associated with the development of different diseases, such as
urinary tract infection, renal carcinoma, urgency urinary
incontinence, overactive bladder, among others. Next, we will
briefly describe what has been reported on this aspect to date.
Urinary Tract Infection
Urinary tract infection (UTI) is one of the most acquired
bacterial infection in humans. Most cases occur as acute
uncomplicated infections in healthy individuals. UTI is
characterized by an initial colonization of the urethral cavity
and a subsequent infection of the lower urinary tract up to the
bladder, causing urethritis and cystitis respectively (Hooton,
2012) . Some infect ions reach the kidneys causing
pyelonephritis and even spread through the bloodstream,
leading to a systemic infection (urosepsis) (Lee and Neild,
2007). UTI has been commonly associated with Escherichia coli
(80% of the cases) but other commensal members of the gut
microbiota, such as Enterococcus, and Staphylococcus, are also
involved (Khasriya et al., 2013). Interestingly, there seems to be a
correlation between an increase in the intestinal abundance of
these genera and a higher prevalence of UTI (Paalanne et al.,
2018; Magruder et al., 2019).
A recent study has described the presence of Escherichia coli
in patients suffering UTI and other urinary disorders, as well as
in healthy individuals. Whole genome sequencing has shown no
differences in the genomic content of virulence factors genes
between strains isolated from patients and healthy individuals.
Only some differences in motility genes between isolates from
UTI patients and healthy individuals were found. Therefore, E.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8coli is part of the commensal urinary microbiota and other
aspects may be determining its involvement in the
development of urinary tract symptoms (Garretto et al., 2020).
Moreover, Escherichia coli has a greater pathogenicity in
polymicrobial infections, mainly when it is isolated together
with Enterococcus, although the mechanisms underlying this
coinfection are not well understood (Lavigne et al., 2008;
Croxall et al., 2011). Along this same line, it has been
described that Enterococcus faecalis can modulate its local
environment through the emission of signals to promote the
growth of other coinfecting organisms. Specifically, E. faecalis
stimulates the growth and survival of Escherichia coli biofilm
through the secretion of L-ornithine, used by Escherichia coli to
synthesize the enterobacterium siderophore under iron limiting
conditions, which would otherwise impede its growth (Keogh
et al., 2016).
In addition, different bacteria from the urinary commensal
microbiota, such as Corynebacterium glucuronolyticum,
Streptococcus gallolyticus, Aerococcus sanguinicola, have been
described as opportunistic uropathogens causing infections
(Jiménez-Guerra et al., 2018; Pereira-Pérez et al., 2019; Ruiz-
Pino et al., 2019).
Similarly, the vaginal microbiota might influence host
susceptibility to UTI. Women with recurrent UTI become
more resistant if their vaginal microbiota is modified by the
administration of probiotics, specifically Lactobacillus crispatus
(Stapleton et al., 2011). Moreover, women with bacterial
vaginosis caused by overgrowth of anaerobic species, such us
some strains belonging to Gardnerella vaginalis, suffer more UTI
than women with healthy microbial communities, composed
mainly of Lactobacillus (Sumati and Saritha, 2009). It has been
shown that temporary exposures to some strains of Gardnerella
vaginalis triggers the activation of Escherichia coli from dormant
intracellular reservoirs in the bladder, enhancing the chance of
developing recurrent UTI through the induction of apoptosis
and interleukin 1-receptor-mediated injury in bladder epithelial
cells (Gilbert et al., 2017). In summary, these results extend the
classic concept of the pathogenesis of UTI, suggesting that the
disease may be driven by occasional exposures of the urinary
tract to gut or vagina-associated bacteria, not traditionally
considered as uropathogenic.
In the last few years, the use of NGS focused on 16S rRNA
gene has revealed that UTI may have a polymicrobial origin
involving the implication of certain bacteria such as
Actinobaculum schaalii and Aerococcus urinae, which might be
overlooked by standard techniques (Domann et al., 2003;
Imirzalioglu et al., 2008; Gomez et al., 2011). This finding has
led to the consideration that some cases of UTI may result from
an imbalance in the urinary microbiota repertoire rather than an
invasion by an exogenous pathogenic organism.
Archaea have been recently reported as members of the
urobiome. Using specific protocols to sequence the archaeal
16S rRNA and culture media for archaeal methanogens
Methanobrevibacter smithii was detected along enterobacteria
in urine samples from patients suffering UTI (Grine et al., 2019).
It has been proposed that this archaeon could trigger a dysbiosisMay 2021 | Volume 11 | Article 617002
Pérez-Carrasco et al. Urinary Microbiomein the urinary microbiota favoring the growth of uropathogens
and, therefore, the development of UTI. However, this
hypothesis requires additional investigation. Methanogens
produce methane as byproduct under anaerobic conditions,
being able to use it to methylate other molecules, such as
heavy metals, and thus producing toxic metabolites for human
and bacterial cells. Methanogens have been previously identified
as part of the microbiota in the gut (Grine et al., 2017; Nkamga
et al., 2017), the oral cavity (Nguyen-Hieu et al., 2013) and the
skin (Probst et al., 2013; Moissl-Eichinger et al., 2017). However,
their role as pathogens has not yet been well established.
Although there is evidence to suggest that some Archaea are
emerging pathogens, further research is required to gain insight
into the methanogen’s repertoire in the human urinary tract and
to understand its possible implication in infections and
other diseases.
One of the main problems for urinary tract surgery is the
appearance of postoperative UTI. The predisposition to suffer
this infection is associated with a decrease in some Lactobacillus
species, such as L. iners, as well as an increase in uropathogens
such as Escherichia coli, Klebsiella pneumoniae or Pseudomonas
aeruginosa. This alteration in the urinary microbiota, along with
other risk factors, such as age or a decrease in estrogen levels,
determine the appearance of postoperative UTI (Figure 4) (Raz,
2011; Thomas-White et al., 2018a).
Different fungal species have been identified in the urine of
individuals with urinary tract symptoms such as Clavispora
lusitaniae, Lodderomyces e longisporus, Meyerozyma
guilliermondii and Malassezia globose, as well as different
species belonging to Candida genus, such as C. albicans, C.
orthopsilosis, C. tropicalis, C. glabrata, C. lusitaniae, among
others (Heras-Cañas et al., 2015; Moustafa et al., 2018).
Microbial identification based on molecular techniques has
allowed a more accurate diagnosis of UTI, detecting bacteria and
other uncultured uropathogenic microorganisms and avoiding
false negative results. In this regard, a better treatment choice is
achieved in patients with urinary tract infection (Ishihara
et al., 2020).
Cancer of the Urinary Tract
Urothelial carcinoma, also known as transitional cell carcinoma
(TCC), is the most common type of bladder cancer. One of the
risk factors for its development is chronic UTI (Akhtar et al.,
2018). Since the microbiota is associated with the development of
cancer in various tissues, it is possible to speculate that it could
also be involved in TCC. However, to date very few studies have
explored the role of microbiome in urologic malignancy, and
most of them with small sample size.
One study compared the microbiome in urine from 31 TCC
patients and 18 healthy controls, finding in TCC patients a higher
abundance of Acinetobacter, Anaerococcus, Sphingobacterium and
members of Sphingobacteriaceae family; pathogenic bacteria such as
Herbaspirillum, Porphyrobacter and Bacteroides were also increased
in TCC patients, as well as urinary infections caused by
Staphylococcus. The authors suggest that microbiome-mediated
modifications in extracellular matrix and its consequentFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9inflammation can play a role in the carcinogenesis (Wu et al.,
2018). A second study analyzed the microbial composition of urine
in 12 TCC patients and 11 controls, noticing an enrichment in
Fusobacterium genera in the TCC group, which has also been
associated with colorectal cancer (Bučević Popović et al., 2018).
Finally, a third report studied the urinary microbiome from 29 TCC
patients and 26 non-cancer patients and found higher abundance of
Actinomyces europaeu in patients suffering from bladder cancer,
which suggests this species may be an indicator for this disease (Bi
et al., 2019).
Recently, one study has analyzed the implication of the
urobiome in prostate cancer comparing the urinary
microbiome in men with positive versus negative diagnosis for
the disease. The study concludes that the presence of pro-
inflammatory or pathogenic bacteria, and those involved in
urinary tract pathologies, such as UTI or prostatitis, favors the
development of prostate cancer (Shrestha et al., 2018). Some of
these bacteria are Actinobaculum schaalii, Anaerococcus
lactolyticus, Varibaculum cambriense, Propionimicrobium
lymphophilum and Ureaplasma species.
All these studies suggest a role of the urinary microbiota in
the development of bladder cancer. However, larger-scale studies
with higher number of patients and, if possible, urine samples
obtained by bladder catheterization will be essential to clarify the
role of urobiome dysbiosis in cancer of the urinary tract.
Urinary Incontinence
Urinary incontinence (UI) is a disorder of the urinary tract
characterized by uncontrolled loss of urine, appearing more
frequently in women. Three types of urinary incontinence have
been described: stress urinary incontinence (SUI), in which urine
loss is associated with cough or physical exertion; urgency
urinary incontinence (UUI), associated with an uncontrollable
desire to urinate; and mixed urinary incontinence (MUI), a
combination of the aforementioned two (Haylen et al., 2010;
Govender et al., 2019). Despite the fact that some risk factors
have been identified, such as age, body mass index, parity or
hormones, there is still a gap in our knowledge when it comes to
UI (Aoki et al., 2017). However, studies based on 16S amplicon
sequencing have established an association between the urinary
microbiota and the development of UI.
One study compared the urobiome in catheterized urine
samples from 60 female patients suffering UUI and 58 healthy
women using sequencing-based methods and the EQUC
technique. UUI patients showed a lower abundance of
Lactobacillus and a higher abundance of Gardnerella, along
with other genera such as Actinobaculum, Actinomyces,
Aerococcus, Arthrobacter, Corynebacterium, Oligel la,
Staphylococcus and Streptococcus (Pearce et al., 2014).
Although Gardnerella has been described as a member of the
commensal urinary microbiota, some Gardnerella strains might
be involved in certain pathologies such as bacterial vaginosis,
allowing the differentiation between pathogenic and commensal
Gardnerella vaginalis strains (Harwich et al., 2010). Additionally,
differences in Lactobacillus species have also been observed
between patients and controls, with an increased abundance ofMay 2021 | Volume 11 | Article 617002
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individuals (Pearce et al., 2014).
Interestingly, a recent study has shown that uropathogenic
bacteria in the urobiome of patients suffering UUI, such as
Escherichia coli or some Gardnerella vaginalis strains, can
induce the release of ATP and a Ca2+ influx into uroepithelial
cells, ultimately favoring the contraction of the smooth muscle
cells in the urinary bladder. On the other hand, Lactobacillus
members impair the production of ATP and the Ca2+ flow
generated by these bacteria, preventing muscle cells
contraction (Abbasian et al., 2019). Therefore, members of the
urinary microbiota might be involved in the contraction of the
urinary bladder contributing to the pathophysiology of UUI.
A second study also analyzed catheterized urine samples from
10 patients suffering UUI and 10 healthy individuals by
sequencing-based methods and identified certain enriched
genera in UUI patients, such as Methylobacterium,
Brevundimonas, Chitinophaga, Sphingomonadales, among
others (Karstens et al., 2016). In addition, authors also
described a reduction in Prevotella, Comamonadaceae,
Nocardioides and Mycobacterium in UUI patients. In general,
14 bacterial genera showing differences in abundance between
patients and controls were identified. Nevertheless, some of the
most abundant genera identified by Pearce et al. (2014) (Pearce
et al., 2014) were not found in this study, which indicates that
additional studies are needed to confirm these results.
To date, few studies have been conducted regarding the other
types of urinary incontinence. One study compared theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10urobiome in catheterized urine samples from 123 women with
MUI and 86 healthy controls. Patients with MUI showed a
decreased relative abundance of Lactobacillus and an increase
in Gardenerella and Prevotella, similar to what had been
previously described in UUI patients (Komesu et al., 2018). In
contrast, a study analyzed the microbial community in
midstream urine samples and some catheterized urine samples
from patients with SUI and found no differences between
patients and healthy individuals (Thomas-White et al., 2017).
These results may be skewed due to the use of midstream urine
samples in the SUI-associated urobiome study, which may
contain microbial contamination. However, it is also possible
that the differences in the urinary microbiome observed in MUI
patients are due to the UUI-associated component of the disease.
Kidney Transplant Dysfunction
One of the main problems in kidney transplantation is the
rejection of the transplant by the recipient and the consequent
dysfunction of the transplanted organ. Interstitial fibrosis and
tubular atrophy (IFTA) are a pathological process triggered by an
excessive accumulation of extracellular matrix and its interaction
with inflammatory cytokines. This injury has been associated
with a reduced survival of the transplanted organ (Nankivell
et al., 2001; Li and Zhuang, 2014).
The relationship between the urinary microbiota and the
development of IFTA was analyzed in a study comparing
midstream urine samples from 25 kidney transplanted patients
with IFTA evidences, 23 patients with normal transplant survivalFIGURE 4 | Risks factors for urinary tract infections related to the microbiota. UTIs may be influenced by different risk factors related to microbial communities:
alterations in the urinary microbiota (either an increase in uropathogens or a decrease in commensal bacteria) (Thomas-White et al., 2018a), alterations in the
intestinal microbiota (increase in uropathogens in the intestinal reservoir) (Magruder et al., 2019) and increasing age, which is related to a decrease in estrogen levels
in women and fluctuations in abundance of Lactobacillus (Thomas-White et al., 2018a).May 2021 | Volume 11 | Article 617002
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a lower abundance of Lactobacillus, in the case of women, and a
lower abundance of Streptococcus, in the case of men, were
detected in patients who showed histological damage
associated with IFTA. Accordingly, an increase in the
abundance of pathogenic bacteria, such as Propionibacterium
acne, Prevotella disiens, Gardnerella vaginalis or Finegoldia
magna, among others, was also found. It is possible that the
enrichment in uropathogens might favor the development of an
enhanced immune response, increasing the chances of transplant
rejection (Modena et al., 2017).
Another study compared the urobiome in kidney
transplanted patients who showed allographic dysfunction and
patients with normal transplant survival. A greater abundance of
Corynebacterium was found in patients with transplant
dysfunction, as well as differences in the abundance of various
genera such as Rhodococcus, Facklamia, Streptococcus or
Fusobacterium, among others (Wu et al., 2018). However, it is
not clear whether these urinary microbiota alterations are the
cause of transplant dysfunction or its consequence. Additional
research on the dysbiosis in the urinary bacterial community and
its association with allographic dysfunction may allow its
early diagnosis.
Other Disorders
Other urinary disorders have been associated with urobiome
dysbiosis. Overactive bladder syndrome (OAB) is a disease
characterized by a constant need to urinate with similar
symptoms as those described for urinary incontinence
(Dhaliwal and Wagg, 2016; Govender et al., 2019). One study
compared the urinary microbiota in midstream urine samples
from 63 female patients suffering OAB and 35 healthy controls.
Patients showed a lower abundance of Lactobacillus and a higher
abundance of Proteus compared to healthy individuals (Curtiss
et al., 2017). These results were supported by a second study in
which the urinary microbiome of 30 OAB patients and 25
healthy individuals was compared using catheterized urine
samples (Wu et al., 2017). A third study analyzed the
urobiome in catheterized urine samples from 126 women
about to undergo urinary surgery. Approximately half of the
patients showed OAB symptoms, being this symptomatology
related to an increased abundance of Atopobium vaginae and
Finegoldia magna. However, the presence of Atopobium vaginae
in patients with these symptoms, as well as in healthy women,
seems to indicate the existence of pathogenic and commensal
strains depending on the surrounding environment (Fok
et al., 2018).
Neuropathic bladder is a urinary disfunction derived from
alterations in the central nervous system, which impair correct
urine storage and emptying of the urinary bladder. This disorder
might favor the appearance of other pathologies such as UTI or
renal dysfunction (Roth and Cain, 2018). A relationship between
the urinary microbiota and the presence of neuropathic bladder
has been verified in a study comparing the urobiome from 24
patients and 23 healthy controls. The urinary microbiota in
patients was characterized by an increased abundance ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 11pathogens, such as Escherichia coli, Enterococcus faecalis,
Pseudomonas aeruginosa, Klebsiella pneumoniae and members
of the Actinobaculum genus, such as A. massiliense, A. schaalii,
A. suis and A. urinale (Groah et al., 2016).
Interstitial cystitis/bladder pain syndrome is characterized by
pain and discomfort in the bladder and lower urinary tract, with
absence of other pathologies such as UTI (Hanno et al., 2011).
One study analyzed the urinary microbiome in midstream urine
from 181 female patients with interstitial cystitis/bladder pain
syndrome and 182 healthy female controls using the PLEX-ID
molecular diagnostic platform, which combines PCR
amplification with mass spectrometry. The authors observed
differences in the abundance of certain bacteria, such as an
increase in Lactobaci l lus gasseri or a reduction in
Corynebacterium and identified exclusive bacteria in patients,
such as Proteus mirabilis, Pseudomonas aeruginosa, Francisella
tularensis, Mycoplasma hyorhinis, Helicobacter hepaticus,
Clostridium perfringens, among others (Nickel et al., 2019). A
similar study demonstrated a higher prevalence of Candida and
Saccharomyces in the urobiome of patients with signs of
interstitial cystitis/bladder pain syndrome, thus being possibly
related to the development of this pathology (Nickel et al., 2016).
However, other recent studies using 16S rRNA gene sequencing
have not identified changes in the urinary microbiota related to
this syndrome (Bresler et al., 2019; Meriwether et al., 2019).
Therefore, more studies are required to reach a consensus on
both positions.
On the other hand, chronic prostatitis/chronic pelvic
syndrome is characterized by similar symptoms as those
described for interstitial cystitis/bladder pain syndrome,
appearing in this case only in men (Polackwich and Shoskes,
2016). This syndrome has also been linked to dysbiosis of the
urinary microbiota. A study comparing the urobiome in
midstream urine samples from 25 male patients and 25 male
healthy controls showed an increase in the abundance of
anaerobic bacteria such as Clostridia, Bacteroides or
Porphyromonas, as well as a decrease in other genera such as
Bacilli. In addition, functional analysis of this community
showed an increase in sporulation pathways, which may be
attributed to resistance mechanisms implemented by Clostridia
(Shoskes et al., 2016).
Nephrolithiasis is a common urological disease characterized
by the presence of calcium-based kidney stones (Wang W. et al.,
2017). This pathological condition has been associated with an
alteration of the urinary microbiota. A recent study comparing
the bacterial community in catheterized urine samples from 22
male patients and 21 male healthy controls described a reduction
in species diversity and an alteration in the microbial community
in patients. Acinetobacter was overrepresented and Prevotella
was reduced in male patients. Prevotella has been described as a
protective bacterium against inflammation through the
production of short-chain fatty acids; therefore, its reduction
promotes a proinflammatory state and formation of kidney
stones (Xie et al., 2020). In addition, a second study has
described the relationship between the urinary microbiota and
the development of hypertension associated with nephrolithiasis.May 2021 | Volume 11 | Article 617002
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urinary microbial community was established in 50 catheterized
patients with kidney stones and different stages of hypertension.
An increase in microbial nitrogen and nucleotide metabolism
and a decrease in adherens junction pathways have been also
described (Liu et al., 2020).
Liu et al. (2017) identified a relationship between type 2
diabetes mellitus, which has a higher prevalence in older
individuals, and urinary microbiota. Elderly individuals suffering
this pathology showed a lower abundance of some phyla, such as
Nitrospirae, Verrucomicrobia and Planctomycetes, as well as a
lower abundance of Lactobacillus genus, although a greater
abundance of L. iners was observed in comparison with healthy
controls. In addition, a recent study analyzed the urobiome of 32
patients suffering type 2 diabetes mellitus and 26 healthy controls
and identified an increase in the relative abundance of 10 genera
associated with type 2 diabetes, such as Escherichia, Shigella,
Klebsiella, Enterococcus and Aerococcus, among others, having
many of them been described as pathogenic bacteria (Chen
et al., 2019).
Therefore, many urinary pathologies are related to urobiome
dysbiosis and its analysis might be a key factor to consider when
designing preventive, diagnostic or therapeutic strategies.URINARY VIROME
The termmicrobiota includes not only bacteria or even fungi, but
also both human and bacteriophage viruses. The set of all viral
genetic material in a certain biological niche is known as virome.
A metagenomic study of whole metagenome shot-gun
sequencing from 49 midstream urine samples has allowed the
identification of different human viruses such as human
papillomavirus, molluscum contagiosum virus, BK and JC
polyomavirus, herpesvirus and anellovirus (Moustafa et al.,
2018). BK polyomavirus has been associated with urinary tract
infections in immunocompromised patients (Paduch, 2007).
However, other human viruses, such as human papillomavirus,
have been identified in patients and in healthy individuals
(Santiago-Rodriguez et al., 2015). JC polyomavirus has been
identified by whole metagenome sequencing in catheterized
urine samples from patients with overactive bladder (Garretto
et al., 2018). The presence of viruses in the urine of patients could
open up a new field of study for the analysis of new mechanisms
for the local transmission of infections, as well as for the design of
innovative preventive measures and new therapeutic strategies.
However, knowledge on the role of human viruses in the urinary
tract is scarce and requires further investigation.
Nevertheless, the urinary virome is mainly formed by
bacteriophages, viruses which infect urinary bacteria such as
Staphylococcus, Escherichia coli or Enterococcus (Santiago-
Rodriguez et al., 2015; Garretto et al., 2018; Moustafa et al.,
2018). Many lytic bacteriophages have been identified in the
urinary tract, like jCTX-like Pseudomonas aeruginosa-infecting
phage isolated from kidney stones (Johnson et al., 2019), or
Escherichia coli-infecting phages isolated from the bladder ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 12women suffering UUI (Malki et al., 2016). Lysogenic phages have
been also detected in the urinary bladder from both healthy
individuals and patients with urinary tract symptoms (Miller-
Ensminger et al., 2018). A thorough review about bacteriophages
in the urinary tract has been recently published (Garretto et al.,
2019), although, for the most part, the role of bacteriophages in
the urinary microbiota remains unknown. These phages could
have an important role in the maintenance of health due to their
ability to infect uropathogenic bacteria in the urinary microbiota.UROBIOME RESEARCH AND
NEW THERAPIES
The recent characterization of the urinary microbiome and its
relationship with disease has led to the development of
urobiome-targeted therapies.
UTI is usually treated with antibiotics and in consequence,
the importance of an accurate bacterial identification has become
more relevant due to the prevalence of broad-spectrum
antibiotic- resistant uropathogens (Cueto et al., 2017). In an
effort to overcome these resistances, it is imperative to use
effective drugs targeted at each specific causative agent. It has
been observed that treatment response in different UTIs varies
depending on the causative pathogen. For instance, cystitis
caused by Aerococcus urinae can be effectively treated with
Nitrofurantoin, while pyelonephritis caused by this same
pathogen can be treated with Ciprofloxacin; however, these
antibiotics are ineffective against infections caused by
Aerococcus sanguinicola, a different species belonging to the
same genus, (Oskooi et al., 2018). The recent identification of a
methanogenic archaea causing UTI has shown that this
uropathogen is resistant to a wide range of antibiotics
commonly used to treat urinary infections such as Fosfomycin,
Cotrimoxazole (Sulfomethoxazole and Trimethoprim),
Amoxicillin-Clavulanate and Ofloxacin (Grine et al., 2019). In
addition, some pathogens, such as Enterococcus faecium, are
resistant to commonly used beta-lactams. The implementation of
non-specific antibiotics in infections is not only ineffective, but it
also causes proliferation of pathogens in the intestinal microbiota
due to the depletion of commensal bacteria, favoring the
appearance of urinary tract infections (Magruder et al., 2019).
Another contributing factor to therapeutic failure is the fact that
some pathogens reside inside cells and are therefore inaccessible to
the majority of drugs. Small concentrations of antibiotics might
access cell cytoplasm, and it has been observed that in the case of
Ciprofloxacin, it triggers the release of adenosine triphosphate
(ATP) by intracellular Escherichica coli with its consequent
increase in Ca2+ flow, thus promoting contractility in the urinary
bladder and the appearance of pathologies such as urgency urinary
incontinence (Abbasian et al., 2019).
Additionally, it has been widely studied that the antibiotics
used against UTI might affect the gut microbiota, causing a
reduction in abundance and diversity and, therefore, intestinal
dysbiosis (Elvers et al., 2020). Similarly, the exposure of the
urinary microbiota to antibiotics might generate an alteration inMay 2021 | Volume 11 | Article 617002
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use of antimicrobial drugs is associated with a dysbiosis of the
urogenital microbiome, although further research is required to
confirm that such dysbiosis is the consequence and not the cause
that initially prompted the treatment (Mulder et al., 2019).
In addition, microbial diversity also determines treatment
response. A study showed that patients suffering urgency urinary
incontinence with a lower diversity in the urinary microbiota had
less serious symptomatology and a greater treatment response to
Solifenacin, compared to those with a greater microbial diversity
(Thomas-White et al., 2016).
Taking all this into consideration, the development of new
therapeutic tools regarding urinary tract disorders is becoming
increasingly relevant. The use of probiotics is a key aspect in this
regard; it has been seen that the intravaginal administration of
probiotic Lactin-V, composed of Lactobacillus crispatus, enables
long-term colonization of the urinary microbiota by commensal
bacteria and a lower incidence of UTI (Stapleton et al., 2011). In
addition, it has been shown that the oral administration of other
species belonging to Lactobacillus genus, such as L. acidophilus
and L. plantarum, along with vitamin A and cranberry extract,
reduces the appearance of UTI (Koradia et al., 2019). The use of
cranberry extract has been shown to inhibit Escherichia coli
adhesins, making it difficult to colonize the urinary bladder
(Howell et al., 2010).
Probiotics can be orally or vaginally administered, although
administration by bladder instillation has been found to be
advantageous over the previous ones since it allows direct
colonization of the urinary bladder. This colonization leads to
a shift in bacterial proportions towards a healthy microbial
composition with positive effects against UTIs (Forster
et al., 2021).
Fecal microbiota transplantation is a recently developed
therapy which is being under consideration against urinary
tract infections. These transplants induce an increase in the
abundance of Lactobacillus and a decrease in the abundance of
Enterobacteriaceae family (Biehl et al., 2018). However, only one
patient was analyzed in this study; a higher number of subjects
would be required to confirm these results. Similarly, in another
study, fecal microbiota transplantation caused a reduction of
UTI incidence and an increased susceptibility of uropathogenic
microorganisms to antibiotics (Tariq et al., 2017).
Finally, considerable effort is being put in the study of lysogenic
bacteriophages (Miller-Ensminger et al., 2018) as therapeutic tools
for urinary tract infections since they were first identified. One study
has shown that three bacteriophages belonging to Syphoviridae,
Myoviridae and Podoviridae subfamilies reduced the levels of UTI-
causing Escherichia coli, including antibiotic resistant strains, both
in in vitro and in vivomurine models (Galtier et al., 2016). A second
study analyzed the effect of bacteriophages administration in
patients with a positive culture for uropathogens. A solution
containing a mixture of active bacteriophages against
Staphylococcus aureus, Escherichia coli, Streptococcus spp.,
Pseudomonas aeruginosa and Proteus spp (Pyo bacteriophage
preparation) was administered to nine patients by intravesical
instillation. The results derived from this study showed thatFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 13bacteriophage administration safely reduced, with no side effects,
levels of Escherichia, Enterococcus, Pseudomonas and Streptococcus,
which can act as urinary tract pathogens (Ujmajuridze et al., 2018).
Therefore, bacteriophages can be used as a possible secure therapy
against uropathogens and as an effective therapy against antibiotic-
resistant bacteria. However, more studies are required to understand
the role of the bacteriophages in the Urinary Tract Health.FUTURE PERSPECTIVES OF
UROBIOME RESEARCH
Given the initial consideration of sterility regarding the urinary
bladder, the study of the microbial community in the urinary
tract has made considerable progress. However, there is still a
long way ahead. Firstly, more studies are needed for the
optimization of the techniques used for microbial identification
and for the establishment of a core microbial community in
healthy individuals. More studies are also needed to analyze
urinary microbial profiles and their association with different
urinary tract pathologies, allowing its use as diagnosis, prognosis
and treatment biomarkers. Secondly, more studies regarding the
relationship of the intestinal microbiota and the urobiome are
required, including its implication in the development of urinary
infections. These types of studies may shed light on prevention
and treatment strategies for UTIs, especially those targeting the
intestinal microbial community, which is known to be a reservoir
for uropathogens (Bahadori et al., 2019; Thänert et al., 2019). In
particular, gaining insight into the mechanisms underlying
interactions between the intestinal and urinary microbiota
might be of great interest for the development of gut
microbiome-targeted therapies for UTIs.
Finally, research on uropathogens physiopathology and their
pathogenicity, as well as on the mode of action of probiotics and its
effectiveness in different scenarios and combinations with other
compounds, might contribute to the development of new additional
therapies apart from antibiotics. Although new therapeutic tools
based on the administration of bacteriophages are in early stages of
development, their study and application are gaining significance.AUTHOR CONTRIBUTIONS
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